Clinical Trials in Casablanca, Morocco
4 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
End Stage Renal DiseasePrimary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company28 enrolled18 locationsNCT04580420
Recruiting
Study Protocol: 10-Year Follow-Up of Patients Screened for Cardiovascular Risk by the "All With Heart" Association - Development of a Morocco-Specific Risk Score
Cardiovascular Diseases (CVD)
Moroccan Society of Cardiology10,000 enrolled2 locationsNCT07294937
Recruiting
Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization.
Arterial Hypertension
Moroccan Society of Cardiology10,000 enrolled5 locationsNCT06769269